X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10122) 10122
Publication (1027) 1027
Newspaper Article (395) 395
Book Review (174) 174
Book Chapter (102) 102
Newsletter (73) 73
Trade Publication Article (45) 45
Magazine Article (23) 23
Book / eBook (18) 18
Conference Proceeding (18) 18
Government Document (14) 14
Dissertation (12) 12
Reference (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (6155) 6155
humans (6115) 6115
index medicus (5490) 5490
prostate cancer (4071) 4071
animals (3398) 3398
androgens (3091) 3091
oncology (2902) 2902
cancer (2052) 2052
androgen receptor (1892) 1892
prostatic neoplasms - drug therapy (1804) 1804
female (1784) 1784
aged (1648) 1648
care and treatment (1553) 1553
middle aged (1515) 1515
urology & nephrology (1426) 1426
prostatic neoplasms - pathology (1419) 1419
testosterone (1368) 1368
toxicology (1367) 1367
androgen antagonists - therapeutic use (1277) 1277
rats (1250) 1250
research (1214) 1214
prostate (1085) 1085
radiotherapy (1058) 1058
analysis (1036) 1036
mice (1022) 1022
health aspects (1017) 1017
metastasis (987) 987
treatment outcome (979) 979
chemotherapy (959) 959
prostatic neoplasms - radiotherapy (916) 916
receptors, androgen - metabolism (913) 913
toxicity (895) 895
pharmacology & pharmacy (855) 855
aged, 80 and over (824) 824
cancer therapies (820) 820
expression (771) 771
apoptosis (741) 741
radical prostatectomy (733) 733
endocrinology & metabolism (730) 730
men (725) 725
cell line, tumor (719) 719
prostatic neoplasms - therapy (683) 683
article (682) 682
therapy (682) 682
prostate-specific antigen - blood (672) 672
estrogen (664) 664
risk factors (653) 653
dose-response relationship, drug (637) 637
adult (632) 632
gene expression (624) 624
androgen (621) 621
androgen deprivation therapy (615) 615
carcinoma (615) 615
biochemistry & molecular biology (609) 609
in-vitro (582) 582
hormones (579) 579
proteins (572) 572
urology (563) 563
patients (561) 561
radiation-therapy (559) 559
androgen-deprivation therapy (557) 557
environmental sciences (551) 551
prostatic neoplasms - metabolism (550) 550
radiology, nuclear medicine & medical imaging (550) 550
clinical trials (542) 542
tumors (539) 539
hematology, oncology and palliative medicine (530) 530
receptors, androgen - genetics (526) 526
survival (526) 526
antineoplastic agents, hormonal - therapeutic use (516) 516
docetaxel (515) 515
physiological aspects (504) 504
medicine (500) 500
testosterone - blood (488) 488
antineoplastic agents - therapeutic use (483) 483
pregnancy (477) 477
prostatic neoplasms - mortality (466) 466
medicine & public health (464) 464
studies (459) 459
castration (455) 455
quality of life (449) 449
radiation therapy (447) 447
orchiectomy (443) 443
time factors (440) 440
cell biology (435) 435
quality-of-life (424) 424
prostatic neoplasms - blood (420) 420
gene-expression (418) 418
androgen antagonists - adverse effects (413) 413
cells (413) 413
development and progression (406) 406
androgen deprivation (404) 404
androgens - metabolism (403) 403
endocrine disruptors - toxicity (400) 400
rats, sprague-dawley (393) 393
disease-free survival (389) 389
drug therapy (389) 389
apoptosis - drug effects (384) 384
prostate-cancer (384) 384
research article (383) 383
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10599) 10599
French (62) 62
German (41) 41
Chinese (19) 19
Japanese (16) 16
Spanish (16) 16
Russian (8) 8
Polish (3) 3
Hungarian (2) 2
Arabic (1) 1
Czech (1) 1
Italian (1) 1
Korean (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 235 - 241
Purpose To characterize the late genitourinary (GU) and gastrointestinal (GI) toxicity for prostate cancer patients treated with intensity-modulated radiation... 
Radiology | Hematology, Oncology and Palliative Medicine | DVH guidelines | IMRT | Late toxicity | Prostate cancer | URINARY TOXICITY | PELVIC RADIOTHERAPY | LATE MORBIDITY | RANDOMIZED CONTROLLED-TRIAL | BIOCHEMICAL CONTROL | ONCOLOGY | BLADDER | 3-DIMENSIONAL CONFORMAL RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ESCALATION | Organs at Risk - radiation effects | Prostatic Neoplasms - radiotherapy | Adenocarcinoma - pathology | Age Factors | Humans | Middle Aged | Urogenital System - radiation effects | Gastrointestinal Tract - radiation effects | Male | Urinary Bladder - radiation effects | Radiotherapy, Intensity-Modulated - adverse effects | Aged, 80 and over | Adult | Prostatic Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Radiotherapy Dosage | Prostatic Neoplasms - pathology | Radiotherapy, Intensity-Modulated - methods | Rectum - radiation effects | Tumor Burden | Proctitis - etiology | Analysis of Variance | Radiation Injuries - prevention & control | Androgen Antagonists - therapeutic use | Aged | Care and treatment | Radiotherapy | Nuclear radiation | Health aspects | Cancer | Adenocarcinoma | Seminal vesicle | Toxicity | Radiation | Radiation therapy | Multivariate analysis | Morbidity | Androgens | Urinary bladder | Rectum | guidelines | Age | Index Medicus | PROSTATE | PATIENTS | DISEASE INCIDENCE | ELDERLY PEOPLE | RECTUM | RADIATION DOSES | TOXICITY | MULTIVARIATE ANALYSIS | RECOMMENDATIONS | MEN | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | ANDROGENS | HAZARDS
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 2004, Volume 201, Issue 3, pp. 226 - 294
Experience with dose response and mechanisms of toxicity has shown that multiple mechanisms may exist for a single agent along the continuum of the full... 
Mechanisms of toxicity | Dose response | Formaldehyde | Zinc | Progesterone/hydroxyflutamide | Propylene oxide | Dose-dependent transitions | Peroxisome proliferator-activated receptor | Acetaminophen | Vinylidene chloride | Butadiene, ethylene glycol | Methylene chloride | Vinyl acetate | Vinyl chloride | Manganese | Progesterone/ hydroxyflutamide | ACETAMINOPHEN-INDUCED HEPATOTOXICITY | propylene oxide | ACTIVATED RECEPTOR-GAMMA | dose-dependent transitions | mechanisms of toxicity | vinylidene chloride | manganese | butadiene | INDUCED HEPATIC-NECROSIS | dose response | ethylene glycol | methylene chloride | PHARMACOLOGY & PHARMACY | TOXICOLOGY | peroxisome proliferator-activated receptor | vinyl acetate | zinc | SISTER-CHROMATID EXCHANGES | SPRAGUE-DAWLEY RATS | MANGANESE OXIDE AEROSOL | formaldehyde | CHRONIC INHALATION TOXICITY | PROTEIN CROSS-LINKS | acetaminophen | vinyl chloride | GLUTATHIONE-S-TRANSFERASE | PARA-BENZOQUINONE IMINE | progesterone/hydroxyflutamide | Analgesics, Non-Narcotic - pharmacokinetics | Progesterone - administration & dosage | Humans | Acetaminophen - administration & dosage | Epoxy Compounds - pharmacokinetics | Dichloroethylenes - toxicity | Manganese - pharmacokinetics | Methylene Chloride - administration & dosage | Analgesics, Non-Narcotic - toxicity | Manganese - administration & dosage | Dichloroethylenes - pharmacokinetics | Dichloroethylenes - administration & dosage | Formaldehyde - toxicity | Androgen Antagonists - toxicity | Ethylene Glycol - toxicity | Butadienes - toxicity | Androgen Antagonists - pharmacokinetics | Progesterone - pharmacokinetics | Oxidation-Reduction | Acetaminophen - toxicity | Vinyl Compounds - administration & dosage | Zinc - toxicity | Androgen Antagonists - administration & dosage | Flutamide - administration & dosage | Vinyl Compounds - toxicity | Zinc - administration & dosage | Peroxisome Proliferator-Activated Receptors - physiology | Drug-Related Side Effects and Adverse Reactions - chemically induced | Flutamide - toxicity | Drug-Related Side Effects and Adverse Reactions - metabolism | Vinyl Compounds - pharmacokinetics | Dose-Response Relationship, Drug | Methylene Chloride - toxicity | Zinc - pharmacokinetics | Epoxy Compounds - administration & dosage | Formaldehyde - administration & dosage | Ethylene Glycol - administration & dosage | Formaldehyde - pharmacokinetics | Ethylene Glycol - pharmacokinetics | Butadienes - pharmacokinetics | Flutamide - analogs & derivatives | Analgesics, Non-Narcotic - administration & dosage | Epoxy Compounds - toxicity | Animals | Butadienes - administration & dosage | Progesterone - toxicity | Methylene Chloride - pharmacokinetics | Acetaminophen - pharmacokinetics | Flutamide - pharmacokinetics | Manganese Poisoning - metabolism
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 95, Issue 1, pp. 435 - 443
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 75, Issue 1, pp. 23 - 28
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2017, Volume 12, Issue 5, pp. e0177902 - e0177902
Journal Article
Circulation, ISSN 0009-7322, 05/2017, Volume 135, Issue 21, pp. 1991 - 2002
BACKGROUND: Millions of individuals have used illicit anabolic-androgenic steroids (AAS), but the long-term cardiovascular associations of these drugs remain... 
Diastolic dysfunction | Cardiology | Cardiomyopathy | Anabolic-androgenic steroids | Atherosclerosis | Men | atherosclerosis | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | MYOCARDIAL-INFARCTION | TESTOSTERONE | PREVALENCE | TISSUE DOPPLER | cardiology | SOCIETY | WEIGHTLIFTERS | VENTRICULAR HYPERTROPHY | anabolic-androgenic steroids | men | diastolic dysfunction | CONSEQUENCES | PERIPHERAL VASCULAR DISEASE | DYSFUNCTION | cardiomyopathy | Coronary Vessels - diagnostic imaging | Diastole | Humans | Middle Aged | Weight Lifting | Male | Systole | Ventricular Dysfunction, Left - chemically induced | Case-Control Studies | Coronary Angiography - methods | Time Factors | Coronary Artery Disease - pathology | Adult | Androgens - adverse effects | Multidetector Computed Tomography | Coronary Vessels - drug effects | Coronary Vessels - pathology | Echocardiography | Cross-Sectional Studies | Risk Assessment | Coronary Artery Disease - chemically induced | Risk Factors | Ventricular Function, Left - drug effects | Stroke Volume - drug effects | Cardiotoxicity | Plaque, Atherosclerotic | Testosterone Congeners - adverse effects | Computed Tomography Angiography | Substance-Related Disorders - complications | Ventricular Dysfunction, Left - diagnostic imaging | Ventricular Dysfunction, Left - physiopathology | Coronary Artery Disease - diagnostic imaging | Performance-Enhancing Substances - adverse effects | Doping in Sports | Anabolic steroids | CT imaging | Usage | Care and treatment | Cardiovascular diseases | Index Medicus | Abridged Index Medicus
Journal Article